Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
Clinical Epigenetics|July 27, 2025
DNA methylation profiling for molecular classification of neuroblastomaMaja Löfgren, Anna Djos, Shiva Rezaei, et al.
Oncogene|April 18, 2003
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2Cecilia Krona, Katarina Ejeskär, Frida Abel, et al.
BMC Genomics|July 31, 2008
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A geneHelena Carén, Jennie Erichsen, Linda Olsson, et al.
Scientific Reports|February 20, 2019
Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor TreatmentNiloufar Javanmardi, Susanne Fransson, Anna Djos, et al.
Cancer Letters|June 25, 2005
NSAIDs in neuroblastoma therapyJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
BMC Cancer|February 15, 2011
Identification of epigenetically regulated genes that predict patient outcome in neuroblastomaHelena Carén, Anna Djos, Maria Nethander, et al.
Cancer Research|October 20, 2004
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivoJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Cancer Letters|May 4, 2025
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progressionJelena Milosevic, Susanne Fransson, Johanna Svensson, et al.
Hereditary Cancer in Clinical Practice|January 21, 2020
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53Meis Omran, Lennart Blomqvist, Yvonne Brandberg, et al.
Pediatric Hematology and Oncology|May 9, 2018
Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factorsKleopatra Georgantzi, Erik G Sköldenberg, Mats Stridsberg, et al.
Pageof 20